2-Chloro-1-methylpyridinium iodide | CAS:14338-32-0

We serve 2-Chloro-1-methylpyridinium iodide CAS:14338-32-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Chloro-1-methylpyridinium iodide

Chemical Name:2-Chloro-1-methylpyridinium iodide
CAS.NO:14338-32-0
Synonyms:2-Chloro-1-methylpyridinium Iodide;CMPI
Molecular Formula:C6H7ClIN
Molecular Weight:255.48400
 
Physical and Chemical Properties:
Melting point:195-200oC;
Index of Refraction:1.546;
 
Specification:
Appearance:Yellow crystalline powder
Purity(HPLC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent



Contact us for information like 2-Chloro-1-methylpyridinium iodide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,CMPI physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Chloro-1-methylpyridinium iodide Use and application,2-Chloro-1-methylpyridinium iodide technical grade,usp/ep/jp grade.


Related News: AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.2,5-Dichlorothiophene manufacturer Major global airports, including London Heathrow, are monitoring people arriving from China for signs of illness.4,4-dimethoxy-N,N-dimethylbutan-1-amine supplier Retrogenix’s proprietary cell microarray technology provides a fast, accurate and effective solution for determining the primary target and secondary target (off-target) activities of antibodies, proteins, cell therapies, small molecules and viruses.(6R,7R)-Benzhydryl 7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate vendor Retrogenix’s proprietary cell microarray technology provides a fast, accurate and effective solution for determining the primary target and secondary target (off-target) activities of antibodies, proteins, cell therapies, small molecules and viruses.GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.”